ANNAPOLIS, Md., Dec. 14 /PRNewswire/ -- PharmAthene, Inc., a privately-
held biotechnology company dedicated to the rapid development of a
comprehensive array of countermeasures to bioterrorism, announced today that
it has received the 'Innovator of the Year' award for new businesses from the
Anne Arundel Technology Council. The Innovator of the Year award recognizes
companies that have exhibited innovative strategies to enter new markets,
create product or service innovations, and demonstrate forward thinking
capabilities to expand market opportunities and grow and expand their
businesses. The awards were handed out during the inaugural 'TechAwards '05 -
- Tech at the Speed of Light' gala held in Annapolis, Maryland.
"We are honored to be recognized by the Anne Arundel Technology Council as
one of the premier innovative technology companies in the region," commented
David P. Wright, President and Chief Executive Officer. "PharmAthene has
established a leading position in the biodefense industry by cultivating a
strong portfolio of novel therapeutic countermeasures essential for the
biosecurity needs of the United States and its allies. In our short history
we have aggressively expanded our technology platform through strategic
collaborations and acquisitions, developed critical relationships with the
U.S. Government, achieved more than $10 million in funding from government
sources, and generated over $70 million in private venture capital to
accelerate our current and future growth. Looking ahead, PharmAthene is well
positioned as the partner of choice for biodefense applications, with the
ability to leverage our capabilities to expand into new biopharmaceutical
markets."
About PharmAthene, Inc.
PharmAthene, a privately-held biotechnology company, was formed to meet
the critical needs of the United States by developing biodefense products.
PharmAthene is dedicated to the rapid development of important and novel
biotherapeutics to address biological pathogens and chemicals that may be used
as weapons of bioterror. PharmAthene's lead programs include Valortim, a
treatment for anthrax, and Protexia(TM), a treatment for nerve agent exposure.
PharmAthene is located in the Chesapeake Innovation Center in Annapolis, MD,
America's first business accelerator for the homeland and national security
sectors. For more information on PharmAthene, please visit
http://www.PharmAthene.com.
About the Anne Arundel Technology Council
Founded in 1992, the Anne Arundel Tech Council is a non-profit
organization designed to provide a forum to further economic development in
the community through the support of innovation and commercialization of
advanced technologies. The mission of the Anne Arundel Tech Council is to
attract new technology companies to Anne Arundel County and help emerging
technology companies grow and prosper in an increasingly dynamic environment.
This is achieved by serving as a resource that meets technology companies'
business, education and networking needs and enhancing public understanding of
technology-related issues.
The Council is the membership association for the technology community in
the Annapolis-Baltimore-Washington region. Members include companies from
throughout the technology sector, including those focusing on information
technology, telecommunications, the Internet, and computer applications and
software. Other members are business support firms, agencies and educational
institutions which provide a wide variety of essential resources for area
technology companies. The Council is advised by a board of dedicated people
representing a wide range of technology businesses, educational institutions
and professional service firms.
SOURCE PharmAthene, Inc.
 back to top
Related links:
http://www.pharmathene.com
CONTACT:
Stacey Jurchison, Director of Education of
PharmAthene, Inc, +1-410-571-8925, or jurchisons@pharmathene.com
|
